According to the outlet, New York-based Pfizer sold over-the-counter ranitidine drugs also known as Zantac from 1998 through 2006. In 2019, a small laboratory in Connecticut found that ranitidine ...
The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.
For those who struggle with heartburn, ranitidine drugs like Zantac can be used for relief. However, after, high levels of a chemical previously known to have been used in rocket fuel were found ...
Shares in GSK and other companies that have been involved in selling Zantac (ranitidine) over the years came under pressure last week, after analysts said liability litigation could end up costing ...
Tests showed that ranitidine, the active ingredient in Zantac, could change into NDMA when exposed to heat. However, GSK, Pfizer and the other companies that have owned it maintain there are no ...
Recently, the heartburn medicine Zantac, also known by its generic name ranitidine, has received pushback from the Food and Drug Administration after it was found to contain potentially high ...
It follows concern in several countries over the presence of impurities in Zantac and other ranitidine products. Canada and France have already announced Zantac recalls. The US and the European ...
As it turns out, impurities in the NDMA found in ranitidine increase when exposed to higher temps and humid conditions. Meaning that the Zantac may have been manufactured correctly, but when it ...
UK doctors are being told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a "precautionary measure". It follows concern in several countries that products ...
such as cimetidine (Tagamet), famotidine (Pepcid), nizatidine (Axid), and ranitidine (Zantac) will very likely provide relief. All of those products are available without a prescription as low ...
In 2020, US regulators halted the sale of Zantac over concerns that a key ingredient, ranitidine, had the potential to turn into a substance that may trigger cancer when exposed to heat.